Back to JANE STREET GROUP, LLC JANE STREET GROUP, LLC

CYPHCYPH
10 quarters

Position history for JANE STREET GROUP, LLCJANE STREET GROUP, LLC's holdings in LEAP THERAPEUTICS INC

Yes. Jane Street Group holds 1,701,926 shares of CYPH (Leap Therapeutics), worth $1M, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$1M

Current Shares

1.7M

Total Value Change

+$1M

Total Shares Change

+1.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
1.7M
-
$1M0.0%$0.61
35
2025-Q4
Exited
0
-100.0%
$00.0%$1.16
0
2025-Q3
New
165,389
-
$75,0870.0%$0.45
33
2025-Q2
Exited
0
-100.0%
$00.0%$0.30
0
2025-Q1
Decreased
32,955
-11.2%
$10,0550.0%$0.31
0
2024-Q4
New
37,098
-
$106,6560.0%$2.88
33
2024-Q3
Exited
0
-100.0%
$00.0%$2.57
0
2024-Q2
New
31,048
-
$60,8540.0%$1.96
32
2023-Q3
Exited
0
-100.0%
$00.0%$1.38
0
2023-Q2
New
11,390
-
$35,6510.0%$3.13
30

Other major holders of CYPH: BALYASNY ASSET MANAGEMENT L.P., BAKER BROS. ADVISORS LP, Point72 Asset Management, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used